BTI
BNTX icon

Blue Trust Inc’s BioNTech BNTX Stock Holding History

Blue Trust Inc’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26K Hold
279
– – ﹤0.01% 1582
2026
Q1 		$24.8K Hold
279
– – ﹤0.01% 1575
2025
Q4 		$26.6K Sell
279
-236
-46% -$23.8K ﹤0.01% 1589
2025
Q3 		$50.8K Sell
515
-13
-2% -$1.39K ﹤0.01% 1409
2025
Q2 		$56.2K Buy
528
+32
+6% +$3.23K ﹤0.01% 1393
2025
Q1 		$45.2K Sell
496
-12
-2% -$1.34K ﹤0.01% 1419
2024
Q4 		$57.9K Buy
508
+41
+9% +$4.68K ﹤0.01% 1209
2024
Q3 		$37.5K Buy
467
+388
+491% +$35.7K ﹤0.01% 1686
2024
Q2 		$7.29K Buy
79
+73
+1,217% +$6.67K ﹤0.01% 2056
2024
Q1 		$554 Sell
6
-112
-95% -$10.7K ﹤0.01% 2005
2023
Q4 		$13K Buy
118
+54
+84% +$5.44K ﹤0.01% 1471
2023
Q3 		$7K Buy
64
+3
+5% +$332 ﹤0.01% 1506
2023
Q2 		$7K Buy
+61
New +$6.86K ﹤0.01% 1408
2023
Q1 		– Sell
-7
Closed -$1K – 2317
2022
Q4 		$1K Buy
7
+2
+40% +$308 ﹤0.01% 2016
2022
Q3 		$0 Sell
5
-49
-91% -$7.49K ﹤0.01% 2094
2022
Q2 		$9K Buy
+54
New +$8.25K ﹤0.01% 1222

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Blue Trust Inc's BNTX Position: Q2 2026 in Review

Blue Trust Inc held its BioNTech (BNTX) position steady in Q2 2026 at 279 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #1582.

Blue Trust Inc first reported a position in BNTX in Q2 2022 and has held it in 16 quarters since. The position peaked at $57.9K in Q4 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Blue Trust Inc held 279 shares of BioNTech worth $26K as of Q2 2026.
  • Blue Trust Inc left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1582 holding.
  • Blue Trust Inc first reported a position in BioNTech in Q2 2022 and has held it in 16 quarters since.
  • Blue Trust Inc's BioNTech position peaked at $57.9K in Q4 2024.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.